In this episode, we talk to Charles Piller, an investigative journalist who published a shocking story in Science magazine in July this year laying out compelling evidence for misconduct in multiple journal articles on Alzheimer’s disease. This misconduct appears to have occurred in recent papers involving the experimental drug, simulfilam, as well as o…
Listen to this episode with a 7-day free trial
Subscribe to Big Biology to listen to this post and get 7 days of free access to the full post archives.
